Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of ($0.48), $0.16 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $53 million versus the consensus estimate of $43.87 million.

GUIDANCE:

Inspire Medical Systems sees FY2021 revenue of $210-213 million, versus the consensus of $195.62 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.